<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">Childhood cancer</z:e> syndromes are rare but easily recognizable in the clinical setting </plain></SENT>
<SENT sid="1" pm="."><plain>Early detection of a potential underlying genetic defect by the general practitioner can be lifesaving </plain></SENT>
<SENT sid="2" pm="."><plain>Additionally, important clinical clues that can aid in recognition, or lead to diagnostic referral, for a possible <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-predisposing syndrome in the individual patient or family are discussed </plain></SENT>
<SENT sid="3" pm="."><plain>RECENT FINDINGS: Recent advancements in genetics have increased our understanding of many genetic developmental pathways involved in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition syndromes </plain></SENT>
<SENT sid="4" pm="."><plain>Importantly, some of the defects in these pathways can explain the wide <z:hpo ids='HP_0003812'>phenotypic variability</z:hpo> in overall growth, physical dysmorphisms, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in children </plain></SENT>
<SENT sid="5" pm="."><plain>Genetic testing is now available for many disorders and important guidelines for screening are quickly evolving </plain></SENT>
<SENT sid="6" pm="."><plain>The current diagnostic criteria, genetics, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> screening guidelines for <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> type 1, <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>/ <z:hpo ids='HP_0001528'>hemihypertrophy</z:hpo>, and PTEN <z:hpo ids='HP_0010566'>hamartoma</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> syndrome, among others, are reviewed </plain></SENT>
<SENT sid="7" pm="."><plain>SUMMARY: Early recognition of a possible underlying genetic defect with a resultant diagnostic work-up can lessen or prevent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden, improve screening for possible <z:e sem="disease" ids="C0920420" disease_type="Neoplastic Process" abbrv="">cancer recurrence</z:e>, and optimize care for children and their family members </plain></SENT>
<SENT sid="8" pm="."><plain>Important clues from the history and physical include a family history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, a specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type frequently associated with a genetic defect, synchronous or metachronous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the same individual, <z:hpo ids='HP_0001507'>growth abnormalities</z:hpo>, <z:mp ids='MP_0002096'>abnormal skin</z:mp> <z:hpo ids='HP_0001000'>pigmentation</z:hpo>, and/or thumb/radius malformations </plain></SENT>
<SENT sid="9" pm="."><plain>Many cases can be recognized by the general practitioner and referred to the appropriate specialists for completion of the diagnostic work-up and recommendations for appropriate management </plain></SENT>
</text></document>